18 June 2013
Keywords: schering, stops, betaferon, trial, ag, stop, its
Article | 16 September 1999
Schering AG will stop its North American trial of Betaferon(interferon beta-1b) in secondary progressive multiple sclerosis based on ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.